Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Theravance Biopharma (TBPH) Shares Repurchased (2022 - 2024)

Theravance Biopharma (TBPH) has disclosed Shares Repurchased for 3 consecutive years, with $445000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Shares Repurchased fell 99.2% to $445000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $445000.0, a N/A change, with the full-year FY2024 number at $445000.0, down 99.77% from a year prior.
  • Shares Repurchased was $445000.0 for Q1 2024 at Theravance Biopharma, down from $55.4 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $55.4 million in Q1 2023 to a low of $445000.0 in Q1 2024.
  • A 3-year average of $30.2 million and a median of $34.8 million in 2022 define the central range for Shares Repurchased.
  • Biggest YoY gain for Shares Repurchased was 99.2% in 2024; the steepest drop was 99.2% in 2024.
  • Theravance Biopharma's Shares Repurchased stood at $34.8 million in 2022, then soared by 59.09% to $55.4 million in 2023, then tumbled by 99.2% to $445000.0 in 2024.
  • Per Business Quant, the three most recent readings for TBPH's Shares Repurchased are $445000.0 (Q1 2024), $55.4 million (Q1 2023), and $34.8 million (Q4 2022).